EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes

Saphala Dhital, Jing Echesabal-Chen, Achala Pokhrel, Ally Brawner, Kun Huang, Rhonda R Powell, Terri Bruce, Lucia Vojtech, Hanjoong Jo, Alexis Stamatikos

Frontiers in Bioscience-Landmark · 10.10.2026 · 31 (10)

DOI: 10.31083/fbl54786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 10.10.2026. Verfasst von Saphala Dhital und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA. Hauptthemen laut MEDLINE: Exosomes, ATP Binding Cassette Transporter 1, Macrophages, Liposomes. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NHLBI R15 Academic Research Enhancement Award (AREA), USDA/NIFA-Hatch Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atherosclerosis is caused by lipid accumulation in arterial endothelial cells and intimal cells. Atherosclerosis generally occurs in arteries that exhibit vascular inflammation, thereby making pro-inflammatory arterial endothelial cells a potential target for delivering atheroprotective material. Lipid-laden macrophages and vascular smooth muscle cells that have transdifferentiated into macrophage-like cells from cholesterol accumulation are the two primary intimal cell types that drive atherosclerosis. We have constructed a novel liposome-based therapeutic system (LP-pXMoA5p) that can specifically target inflamed arterial endothelial cells, resulting in endothelial cells that internalize LP-pXMoA5p to express and then package anti-miR-33a-5p into exosomes that are released basolaterally, which may lead to effective transfer of atheroprotective anti-miR-33a-5p to intimal cells. We have previously tested this delivery method with cultured macrophages being the recipient of endothelial-cell-derived exosomes filled with anti-miR-33a-5p, resulting in enhanced macrophage ABCA1-dependent cholesterol efflux.

Methods

In this study, we wanted to test whether our LP-pXMoA5p delivery system is successful when utilizing cultured macrophage-like cells as the recipient cells for endothelial-cell-derived exosomes loaded with anti-miR-33a-5p. To test the atheroprotective efficacy of our LP-pXMoA5p delivery method, we measured miR-33a-5p expression, ABCA1 protein expression, and apoAI-mediated cholesterol efflux in recipient macrophage-like cells.

Results

In our experiments, we observed that cultured macrophage-like cells incubated with anti-miR-33a-5p-filled exosomes exhibited high levels of cellular anti-miR-33a-5p, which resulted in decreased miR-33a-5p expression. Moreover, inhibition of miR-33a-5p within macrophage-like cells caused enhanced apoAI-mediated cholesterol efflux in these cells, which was likely the result of increased ABCA1 protein expression.

Conclusions

Our findings reveal that LP-pXMoA5p appears capable of enhancing ABCA1-dependent cholesterol efflux within cultured macrophage-like cells, with this outcome potentially being due to macrophage-like cells internalizing anti-miR-33a-5p-loaded exosomes which are secreted by pro-inflammatory cultured immortalized mouse aortic endothelial cells (iMAECs), but we acknowledge this may not translate to similar effects in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesATP Binding Cassette Transporter 1MacrophagesLiposomesEndothelial CellsAtherosclerosisInflammationEndothelium, VascularAnimalsMicroRNAsMiceHumansUp-RegulationCholesterol

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseaseextracellular vesiclehigh-density lipoproteinischemic heart diseaselow-density lipoproteinnanoparticlereverse cholesterol transportvascular inflammation

Substanzen

ATP Binding Cassette Transporter 1LiposomesMicroRNAsCholesterolMirn33 microRNA, mouse

Autor:innen und Institutionen

  • Department of Food, Nutrition, and Packaging Sciences, Clemson University, Clemson, SC 29634, USA.
  • Department of Bioengineering, Clemson University, Clemson, SC 29634, USA.
  • Clemson Light Imaging Facility, Clemson University, Clemson, SC 29634, USA.
  • Department of Obstetrics & Gynecology, University of Washington, Seattle, WA 98109, USA.
  • Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
  • School of Health and Human Sciences, South Dakota State University, Brookings, SD 57007, USA.

Förderung

  • NIH/NHLBI R15 Academic Research Enhancement Award (AREA)
  • USDA/NIFA-Hatch Project

Zitieren

APA

Dhital, S., Echesabal-Chen, J., Pokhrel, A., Brawner, A., Huang, K., Powell, R. R., Bruce, T., Vojtech, L., Jo, H., & Stamatikos, A. (2026). Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl54786

Vancouver

Dhital S, Echesabal-Chen J, Pokhrel A, Brawner A, Huang K, Powell RR, et al. Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl54786

BibTeX
@article{Dhital2026,
  author = {Dhital, Saphala and Echesabal-Chen, Jing and Pokhrel, Achala and Brawner, Ally and Huang, Kun and Powell, Rhonda R and Bruce, Terri and Vojtech, Lucia and Jo, Hanjoong and Stamatikos, Alexis},
  title = {Utilizing Liposomes That Selectively Target Inflamed Endothelium to Upregulate Macrophage-Like Cell ABCA1 Through Endothelial Cell-Derived Exosome-Mediated Processes},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {10},
  doi = {10.31083/fbl54786}
}
Kostenlos starten →